APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phage Therapy

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

Selected research

Industry Growth & Trends

Global Phage Therapy Industry Growth and Trends Forecast to 2032

29 December 2025124 pages

Choose your research edition.

Industry ResearchPhage Therapy Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Phage Therapy Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Phage Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phage Therapy Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Phage Therapy Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.

According to APO Research, the global Phage Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Phage Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Phage Therapy market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Phage Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Phage Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Phage Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Phage Therapy Market by Company

NPO Microgen

Proteon Pharmaceuticals

Phagelux

Intralytix

Micreos

Eliava BioPreparations

Locus Biosciences,Inc

Pharmex Group,LLC

Pherecydes Pharma

APS Biocontrol Ltd. (APS)

Qingdao Phagepharm Bio-tech

Fixed-Phage Limited

Zeptometrix

Phage International, Inc.

MicroMir

iNtODEWORLD, Inc.

NEXTBIOTICS

Armata Pharmaceuticals, Inc.

Innophage

Adaptive Phage Therapeutics

TechnoPhage

Phage Therapy Segment by Type

DsDNA Bacteriophage

SsDNA Bacteriophage

SsRNA Bacteriophage

Others

Phage Therapy Segment by Application

Animal Health

Aquaculture

Agriculture

Food Industry

Human Health

Others

Phage Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Phage Therapy companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Phage Therapy Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Phage Therapy Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Phage Therapy Market Share by Region (2021-2026) Table 4. Global Phage Therapy Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Phage Therapy Market Share by Region (2027-2032) Table 6. Global Phage Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Phage Therapy Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Phage Therapy Market Size Share by Type (2021-2026) Table 9. Global Phage Therapy Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Phage Therapy Market Size Share Forecasted by Type (2027-2032) Table 11. North America Phage Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Phage Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Phage Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Phage Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Phage Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Phage Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Phage Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Phage Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Phage Therapy Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Phage Therapy Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Phage Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Phage Therapy Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Phage Therapy Market Size Share by Application (2021-2026) Table 24. Global Phage Therapy Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Phage Therapy Market Size Share Forecasted by Application (2027-2032) Table 26. North America Phage Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Phage Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Phage Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Phage Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Phage Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Phage Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Phage Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Phage Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Phage Therapy Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Phage Therapy Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Phage Therapy Industry Trends Table 37. Phage Therapy Industry Drivers Table 38. Phage Therapy Industry Opportunities and Challenges Table 39. Phage Therapy Industry Restraints Table 40. Global Phage Therapy Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Phage Therapy Revenue Market Share by Company (2021-2026) Table 42. Global Phage Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Phage Therapy Key Company Headquarters & Area Served Table 44. Global Phage Therapy Company, Product Type & Application Table 45. Global Phage Therapy Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Phage Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. NPO Microgen Company Information Table 49. NPO Microgen Business Overview Table 50. NPO Microgen Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. NPO Microgen Phage Therapy Product Portfolio Table 52. NPO Microgen Recent Development Table 53. Proteon Pharmaceuticals Company Information Table 54. Proteon Pharmaceuticals Business Overview Table 55. Proteon Pharmaceuticals Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Proteon Pharmaceuticals Phage Therapy Product Portfolio Table 57. Proteon Pharmaceuticals Recent Development Table 58. Phagelux Company Information Table 59. Phagelux Business Overview Table 60. Phagelux Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Phagelux Phage Therapy Product Portfolio Table 62. Phagelux Recent Development Table 63. Intralytix Company Information Table 64. Intralytix Business Overview Table 65. Intralytix Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Intralytix Phage Therapy Product Portfolio Table 67. Intralytix Recent Development Table 68. Micreos Company Information Table 69. Micreos Business Overview Table 70. Micreos Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Micreos Phage Therapy Product Portfolio Table 72. Micreos Recent Development Table 73. Eliava BioPreparations Company Information Table 74. Eliava BioPreparations Business Overview Table 75. Eliava BioPreparations Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Eliava BioPreparations Phage Therapy Product Portfolio Table 77. Eliava BioPreparations Recent Development Table 78. Locus Biosciences,Inc Company Information Table 79. Locus Biosciences,Inc Business Overview Table 80. Locus Biosciences,Inc Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Locus Biosciences,Inc Phage Therapy Product Portfolio Table 82. Locus Biosciences,Inc Recent Development Table 83. Pharmex Group,LLC Company Information Table 84. Pharmex Group,LLC Business Overview Table 85. Pharmex Group,LLC Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pharmex Group,LLC Phage Therapy Product Portfolio Table 87. Pharmex Group,LLC Recent Development Table 88. Pherecydes Pharma Company Information Table 89. Pherecydes Pharma Business Overview Table 90. Pherecydes Pharma Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Pherecydes Pharma Phage Therapy Product Portfolio Table 92. Pherecydes Pharma Recent Development Table 93. APS Biocontrol Ltd. (APS) Company Information Table 94. APS Biocontrol Ltd. (APS) Business Overview Table 95. APS Biocontrol Ltd. (APS) Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio Table 97. APS Biocontrol Ltd. (APS) Recent Development Table 98. Qingdao Phagepharm Bio-tech Company Information Table 99. Qingdao Phagepharm Bio-tech Business Overview Table 100. Qingdao Phagepharm Bio-tech Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio Table 102. Qingdao Phagepharm Bio-tech Recent Development Table 103. Fixed-Phage Limited Company Information Table 104. Fixed-Phage Limited Business Overview Table 105. Fixed-Phage Limited Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Fixed-Phage Limited Phage Therapy Product Portfolio Table 107. Fixed-Phage Limited Recent Development Table 108. Zeptometrix Company Information Table 109. Zeptometrix Business Overview Table 110. Zeptometrix Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Zeptometrix Phage Therapy Product Portfolio Table 112. Zeptometrix Recent Development Table 113. Phage International, Inc. Company Information Table 114. Phage International, Inc. Business Overview Table 115. Phage International, Inc. Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Phage International, Inc. Phage Therapy Product Portfolio Table 117. Phage International, Inc. Recent Development Table 118. MicroMir Company Information Table 119. MicroMir Business Overview Table 120. MicroMir Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. MicroMir Phage Therapy Product Portfolio Table 122. MicroMir Recent Development Table 123. iNtODEWORLD, Inc. Company Information Table 124. iNtODEWORLD, Inc. Business Overview Table 125. iNtODEWORLD, Inc. Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. iNtODEWORLD, Inc. Phage Therapy Product Portfolio Table 127. iNtODEWORLD, Inc. Recent Development Table 128. NEXTBIOTICS Company Information Table 129. NEXTBIOTICS Business Overview Table 130. NEXTBIOTICS Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. NEXTBIOTICS Phage Therapy Product Portfolio Table 132. NEXTBIOTICS Recent Development Table 133. Armata Pharmaceuticals, Inc. Company Information Table 134. Armata Pharmaceuticals, Inc. Business Overview Table 135. Armata Pharmaceuticals, Inc. Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio Table 137. Armata Pharmaceuticals, Inc. Recent Development Table 138. Innophage Company Information Table 139. Innophage Business Overview Table 140. Innophage Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Innophage Phage Therapy Product Portfolio Table 142. Innophage Recent Development Table 143. Adaptive Phage Therapeutics Company Information Table 144. Adaptive Phage Therapeutics Business Overview Table 145. Adaptive Phage Therapeutics Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Adaptive Phage Therapeutics Phage Therapy Product Portfolio Table 147. Adaptive Phage Therapeutics Recent Development Table 148. TechnoPhage Company Information Table 149. TechnoPhage Business Overview Table 150. TechnoPhage Phage Therapy Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. TechnoPhage Phage Therapy Product Portfolio Table 152. TechnoPhage Recent Development Table 153. North America Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Phage Therapy Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Phage Therapy Market Share by Country (2021-2026) Table 156. North America Phage Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Phage Therapy Market Share Forecast by Country (2027-2032) Table 158. Europe Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Phage Therapy Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Phage Therapy Market Share by Country (2021-2026) Table 161. Europe Phage Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Phage Therapy Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Phage Therapy Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Phage Therapy Market Share by Country (2021-2026) Table 166. Asia-Pacific Phage Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Phage Therapy Market Share Forecast by Country (2027-2032) Table 168. Latin America Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Phage Therapy Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Phage Therapy Market Share by Country (2021-2026) Table 171. Latin America Phage Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Phage Therapy Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Phage Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Phage Therapy Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Phage Therapy Market Share by Country (2021-2026) Table 176. Middle East & Africa Phage Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Phage Therapy Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Phage Therapy Product Image Figure 3. Global Phage Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Phage Therapy Market Size (2021-2032) & (US$ Million) Figure 5. Global Phage Therapy Market Share by Region: 2025 VS 2032 Figure 6. Global Phage Therapy Market Share by Region (2021-2032) Figure 7. North America Phage Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Phage Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Phage Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Phage Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Phage Therapy Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. DsDNA Bacteriophage Image Figure 13. Global DsDNA Bacteriophage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. SsDNA Bacteriophage Image Figure 15. Global SsDNA Bacteriophage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. SsRNA Bacteriophage Image Figure 17. Global SsRNA Bacteriophage Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Phage Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Phage Therapy Market Share by Type 2025 VS 2032 Figure 22. North America Phage Therapy Market Size Share by Type (2021-2032) Figure 23. Europe Phage Therapy Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Phage Therapy Market Size Share by Type (2021-2032) Figure 25. Latin America Phage Therapy Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Phage Therapy Market Size Share by Type (2021-2032) Figure 27. Animal Health Image Figure 28. Global Animal Health Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Aquaculture Image Figure 30. Global Aquaculture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Agriculture Image Figure 32. Global Agriculture Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Food Industry Image Figure 34. Global Food Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Human Health Image Figure 36. Global Human Health Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Others Image Figure 38. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Phage Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Phage Therapy Market Share by Application 2025 VS 2032 Figure 41. North America Phage Therapy Market Size Share by Application (2021-2032) Figure 42. Europe Phage Therapy Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Phage Therapy Market Size Share by Application (2021-2032) Figure 44. Latin America Phage Therapy Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Phage Therapy Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Phage Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Phage Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Phage Therapy Market Share by Country (2021-2032) Figure 51. Europe Phage Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Phage Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Phage Therapy Market Share by Country (2021-2032) Figure 54. Asia-Pacific Phage Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Phage Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Phage Therapy Market Share by Country (2021-2032) Figure 57. Latin America Phage Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Phage Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Phage Therapy Market Share by Country (2021-2032) Figure 60. Middle East & Africa Phage Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Phage Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Phage Therapy Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • DsDNA Bacteriophage
  • SsDNA Bacteriophage
  • SsRNA Bacteriophage
  • Others
Applications
  • Animal Health
  • Aquaculture
  • Agriculture
  • Food Industry
  • Human Health
  • Others
Companies covered
  • NPO Microgen
  • Proteon Pharmaceuticals
  • Phagelux
  • Intralytix
  • Micreos
  • Eliava BioPreparations
  • Locus Biosciences,Inc
  • Pharmex Group,LLC
  • Pherecydes Pharma
  • APS Biocontrol Ltd. (APS)
  • Qingdao Phagepharm Bio-tech
  • Fixed-Phage Limited
  • Zeptometrix
  • Phage International, Inc.
  • MicroMir
  • iNtODEWORLD, Inc.
  • NEXTBIOTICS
  • Armata Pharmaceuticals, Inc.
  • Innophage
  • Adaptive Phage Therapeutics
  • TechnoPhage

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Phage Therapy Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Phage Therapy Market Size by Region (2021-2032)
  5. 1.4.1 Global Phage Therapy Market Size by Region (2021-2026)
  6. 1.4.2 Global Phage Therapy Market Size by Region (2027-2032)
  7. 1.5 Key Regions Phage Therapy Market Size (2021-2032)
  8. 1.5.1 North America Phage Therapy Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Phage Therapy Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Phage Therapy Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Phage Therapy Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Phage Therapy Market Size Growth Rate (2021-2032)
2 Phage Therapy Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 DsDNA Bacteriophage
  3. 2.1.2 SsDNA Bacteriophage
  4. 2.1.3 SsRNA Bacteriophage
  5. 2.1.4 Others
  6. 2.2 Global Phage Therapy Market Size by Type
  7. 2.2.1 Global Phage Therapy Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Phage Therapy Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Phage Therapy Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Phage Therapy Market Size by Regions
  11. 2.3.1 North America Phage Therapy Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Phage Therapy Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Phage Therapy Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Phage Therapy Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Phage Therapy Market Size Breakdown by Type (2021-2026)
3 Phage Therapy Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Animal Health
  3. 3.1.2 Aquaculture
  4. 3.1.3 Agriculture
  5. 3.1.4 Food Industry
  6. 3.1.5 Human Health
  7. 3.1.6 Others
  8. 3.2 Global Phage Therapy Market Size by Application
  9. 3.2.1 Global Phage Therapy Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global Phage Therapy Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global Phage Therapy Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global Phage Therapy Market Size by Regions
  13. 3.3.1 North America Phage Therapy Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe Phage Therapy Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific Phage Therapy Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America Phage Therapy Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa Phage Therapy Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Phage Therapy Industry Trends
  2. 4.2 Phage Therapy Industry Drivers
  3. 4.3 Phage Therapy Industry Opportunities and Challenges
  4. 4.4 Phage Therapy Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Phage Therapy Revenue (2021-2026)
  2. 5.2 Global Phage Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Phage Therapy Key Company Headquarters & Area Served
  4. 5.4 Global Phage Therapy Company, Product Type & Application
  5. 5.5 Global Phage Therapy Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Phage Therapy Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Phage Therapy Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Phage Therapy Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 NPO Microgen
  2. 6.1.1 NPO Microgen Company Information
  3. 6.1.2 NPO Microgen Business Overview
  4. 6.1.3 NPO Microgen Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 NPO Microgen Phage Therapy Product Portfolio
  6. 6.1.5 NPO Microgen Recent Developments
  7. 6.2 Proteon Pharmaceuticals
  8. 6.2.1 Proteon Pharmaceuticals Company Information
  9. 6.2.2 Proteon Pharmaceuticals Business Overview
  10. 6.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Proteon Pharmaceuticals Phage Therapy Product Portfolio
  12. 6.2.5 Proteon Pharmaceuticals Recent Developments
  13. 6.3 Phagelux
  14. 6.3.1 Phagelux Company Information
  15. 6.3.2 Phagelux Business Overview
  16. 6.3.3 Phagelux Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Phagelux Phage Therapy Product Portfolio
  18. 6.3.5 Phagelux Recent Developments
  19. 6.4 Intralytix
  20. 6.4.1 Intralytix Company Information
  21. 6.4.2 Intralytix Business Overview
  22. 6.4.3 Intralytix Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Intralytix Phage Therapy Product Portfolio
  24. 6.4.5 Intralytix Recent Developments
  25. 6.5 Micreos
  26. 6.5.1 Micreos Company Information
  27. 6.5.2 Micreos Business Overview
  28. 6.5.3 Micreos Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Micreos Phage Therapy Product Portfolio
  30. 6.5.5 Micreos Recent Developments
  31. 6.6 Eliava BioPreparations
  32. 6.6.1 Eliava BioPreparations Company Information
  33. 6.6.2 Eliava BioPreparations Business Overview
  34. 6.6.3 Eliava BioPreparations Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Eliava BioPreparations Phage Therapy Product Portfolio
  36. 6.6.5 Eliava BioPreparations Recent Developments
  37. 6.7 Locus Biosciences,Inc
  38. 6.7.1 Locus Biosciences,Inc Company Information
  39. 6.7.2 Locus Biosciences,Inc Business Overview
  40. 6.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Locus Biosciences,Inc Phage Therapy Product Portfolio
  42. 6.7.5 Locus Biosciences,Inc Recent Developments
  43. 6.8 Pharmex Group,LLC
  44. 6.8.1 Pharmex Group,LLC Company Information
  45. 6.8.2 Pharmex Group,LLC Business Overview
  46. 6.8.3 Pharmex Group,LLC Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pharmex Group,LLC Phage Therapy Product Portfolio
  48. 6.8.5 Pharmex Group,LLC Recent Developments
  49. 6.9 Pherecydes Pharma
  50. 6.9.1 Pherecydes Pharma Company Information
  51. 6.9.2 Pherecydes Pharma Business Overview
  52. 6.9.3 Pherecydes Pharma Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Pherecydes Pharma Phage Therapy Product Portfolio
  54. 6.9.5 Pherecydes Pharma Recent Developments
  55. 6.10 APS Biocontrol Ltd. (APS)
  56. 6.10.1 APS Biocontrol Ltd. (APS) Company Information
  57. 6.10.2 APS Biocontrol Ltd. (APS) Business Overview
  58. 6.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 APS Biocontrol Ltd. (APS) Phage Therapy Product Portfolio
  60. 6.10.5 APS Biocontrol Ltd. (APS) Recent Developments
  61. 6.11 Qingdao Phagepharm Bio-tech
  62. 6.11.1 Qingdao Phagepharm Bio-tech Company Information
  63. 6.11.2 Qingdao Phagepharm Bio-tech Business Overview
  64. 6.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Qingdao Phagepharm Bio-tech Phage Therapy Product Portfolio
  66. 6.11.5 Qingdao Phagepharm Bio-tech Recent Developments
  67. 6.12 Fixed-Phage Limited
  68. 6.12.1 Fixed-Phage Limited Company Information
  69. 6.12.2 Fixed-Phage Limited Business Overview
  70. 6.12.3 Fixed-Phage Limited Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Fixed-Phage Limited Phage Therapy Product Portfolio
  72. 6.12.5 Fixed-Phage Limited Recent Developments
  73. 6.13 Zeptometrix
  74. 6.13.1 Zeptometrix Company Information
  75. 6.13.2 Zeptometrix Business Overview
  76. 6.13.3 Zeptometrix Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Zeptometrix Phage Therapy Product Portfolio
  78. 6.13.5 Zeptometrix Recent Developments
  79. 6.14 Phage International, Inc.
  80. 6.14.1 Phage International, Inc. Company Information
  81. 6.14.2 Phage International, Inc. Business Overview
  82. 6.14.3 Phage International, Inc. Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Phage International, Inc. Phage Therapy Product Portfolio
  84. 6.14.5 Phage International, Inc. Recent Developments
  85. 6.15 MicroMir
  86. 6.15.1 MicroMir Company Information
  87. 6.15.2 MicroMir Business Overview
  88. 6.15.3 MicroMir Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 MicroMir Phage Therapy Product Portfolio
  90. 6.15.5 MicroMir Recent Developments
  91. 6.16 iNtODEWORLD, Inc.
  92. 6.16.1 iNtODEWORLD, Inc. Company Information
  93. 6.16.2 iNtODEWORLD, Inc. Business Overview
  94. 6.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 iNtODEWORLD, Inc. Phage Therapy Product Portfolio
  96. 6.16.5 iNtODEWORLD, Inc. Recent Developments
  97. 6.17 NEXTBIOTICS
  98. 6.17.1 NEXTBIOTICS Company Information
  99. 6.17.2 NEXTBIOTICS Business Overview
  100. 6.17.3 NEXTBIOTICS Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 NEXTBIOTICS Phage Therapy Product Portfolio
  102. 6.17.5 NEXTBIOTICS Recent Developments
  103. 6.18 Armata Pharmaceuticals, Inc.
  104. 6.18.1 Armata Pharmaceuticals, Inc. Company Information
  105. 6.18.2 Armata Pharmaceuticals, Inc. Business Overview
  106. 6.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Armata Pharmaceuticals, Inc. Phage Therapy Product Portfolio
  108. 6.18.5 Armata Pharmaceuticals, Inc. Recent Developments
  109. 6.19 Innophage
  110. 6.19.1 Innophage Company Information
  111. 6.19.2 Innophage Business Overview
  112. 6.19.3 Innophage Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Innophage Phage Therapy Product Portfolio
  114. 6.19.5 Innophage Recent Developments
  115. 6.20 Adaptive Phage Therapeutics
  116. 6.20.1 Adaptive Phage Therapeutics Company Information
  117. 6.20.2 Adaptive Phage Therapeutics Business Overview
  118. 6.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Adaptive Phage Therapeutics Phage Therapy Product Portfolio
  120. 6.20.5 Adaptive Phage Therapeutics Recent Developments
  121. 6.21 TechnoPhage
  122. 6.21.1 TechnoPhage Company Information
  123. 6.21.2 TechnoPhage Business Overview
  124. 6.21.3 TechnoPhage Phage Therapy Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 TechnoPhage Phage Therapy Product Portfolio
  126. 6.21.5 TechnoPhage Recent Developments
7 North America
  1. 7.1 North America Phage Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Phage Therapy Market Size by Country (2021-2026)
  3. 7.3 North America Phage Therapy Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Phage Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Phage Therapy Market Size by Country (2021-2026)
  3. 8.3 Europe Phage Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Phage Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Phage Therapy Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Phage Therapy Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Phage Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Phage Therapy Market Size by Country (2021-2026)
  3. 10.3 South America Phage Therapy Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Phage Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Phage Therapy Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Phage Therapy Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst